• Prevent Blindness

    Using Artificial Intelligence

  • Instantaneous Report, in a Single Office Visit.

    Under 60 Seconds

  • Fully Automated.

    No Human Grading.

About Us

About Us

Diabeato is the eminent provider of world’s most extensively validated Artificial Intelligence (AI) based technology for autonomous detection of diabetic retinopathy, tested on over half a million patient visits globally with over two million images collected in real-world clinical environments.

We work with Diabetologists and Ophthalmologists to collectively help over 65 million diabetic and pre-diabetic patients across the country.
We enable identification of patients with vision-threatening retinopathy in-clinic, in real-time, so they can be immediately referred to an eyecare specialist for treatment to save their sight.

Diabetic Retinopathy

Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It’s caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).
At first, diabetic retinopathy may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition can develop in anyone who has type 1 or type 2 diabetes. The longer you have diabetes and the less controlled your blood sugar is, the more likely you are to develop this eye complication.

What is diabetic retinopathy

Stages of Diabetic Eye Disease

There are two main stages of diabetic eye disease.

NPDR (non-proliferative diabetic retinopathy)

Early stage of diabetic eye disease. Many people with diabetes have it.

More Information

PDR (proliferative diabetic retinopathy)

PDR is the more advanced stage of diabetic eye disease

More Information

Non-proliferative Diabetic Retinopathy

With NPDR, tiny blood vessels leak, making the retina swell. When the macula swells, it is called macular edema. This is the most common reason why people with diabetes lose their vision. Also with NPDR, blood vessels in the retina can close off. This is called macular ischemia. When that happens, blood cannot reach the macula. Sometimes tiny particles called exudates can form in the retina. These can affect your vision too. If you have NPDR, your vision will be blurry.

Proliferative Diabetic Retinopathy

PDR happens when the retina starts growing new blood vessels. This is called neovascularization. These fragile new vessels often bleed into the vitreous. If they only bleed a little, you might see a few dark floaters. If they bleed a lot, it might block all vision. These new blood vessels can form scar tissue. Scar tissue can cause problems with the macula or lead to a detached retina. PDR is very serious, and can steal both your central and peripheral (side) vision.

Source: American Academy of Ophthalmology

Why Screen

With the global diabetic population estimated at 371 million, the impact of diabetic retinopathy is profound, garnering substantial attention from the medical community at large. Fortunately, DR is both routinely detectable and highly treatable, particularly when addressed in its earlier stages. In addition, significant technological advancements have been made recently to further address the issue.

All people with diabetes, both type I and type II, are at risk of developing diabetic retinopathy. The longer a person has had diabetes, the greater the risk that they will develop DR. It is reported that, after 20 years of having diabetes, nearly 100% of those with type I and over 60% of those with type II will have developed some degree of retinopathy. It is recommended that all people with diabetes who have not been screened do so at the earliest convenience and continue to undergo screenings every two years thereafter. With regular screenings and proper maintenance of the diabetic condition, the risk and effects of diabetic retinopathy can be minimized or eliminated entirely, keeping patients’ eyesight intact and allowing them to enjoy a full, uninhibited lifestyle.

What We Do

Immediate, Fully-automated, On-site Screening

Trained Operator Captures Image Using a Fundus Camera

AI Disease Detection

Generate Human Expert Grading Report

Screening Report Signed By Eye Care Professional

The Diabeto Screening System makes in-clinic, real-time diabetic retinopathy (DR) screening possible for primary care practices, diabetes centers and optometric offices by allowing physicians to quickly and accurately identify referable DR patients during a diabetic patient’s regular exam.

Any physician can quickly and accurately detect referable diabetic retinopathy patients during a diabetic patient’s regular exam with a report that is generated in less than 60 seconds after submission of patient images.

Contact Us

Get in touch

We would love to hear from you

407 Silver Radiance, Pakwan Char Rasta,

Sindhu Bhavan Road, Bodakdev,

Ahmedabad 380054

+91 70439 46008

info@infinionbiopharma.com

CrestaProject

  • Home
  • About Us
  • Diabetic Retinopathy
  • Why Screen
  • What We Do
  • Contact Us